Lazar, M. A. How obesity causes diabetes: not a tall tale. Science 307, 373–375 (2005).
Tracey, K. J. The inflammatory reflex. Nature 420, 853–859 (2002).
Abel, E. D. et al. Diabetes mellitus — progress and opportunities in the evolving epidemic. Cell 187, 3789–3820 (2024).
Yao, G. et al. Effective weight control via an implanted self-powered vagus nerve stimulation device. Nat. Commun. 9, 5349 (2018).
Mirza, K. B., Golden, C. T., Nikolic, K. & Toumazou, C. Closed-loop implantable therapeutic neuromodulation systems based on neurochemical monitoring. Front. Neurosci. 13, 808 (2019).
Kawana, Y. et al. Optogenetic stimulation of vagal nerves for enhanced glucose-stimulated insulin secretion and beta cell proliferation. Nat. Biomed. Eng. 8, 808–822 (2024).
Rohm, T. V., Meier, D. T., Olefsky, J. M. & Donath, M. Y. Inflammation in obesity, diabetes, and related disorders. Immunity 55, 31–55 (2022).
Shaikh, S. R., Beck, M. A., Alwarawrah, Y. & MacIver, N. J. Emerging mechanisms of obesity-associated immune dysfunction. Nat. Rev. Endocrinol. 20, 136–148 (2024).
Le Thuc, O. & Garcia-Caceres, C. Obesity-induced inflammation: connecting the periphery to the brain. Nat. Metab. 6, 1237–1252 (2024).
Katsarou, A. et al. Type 1 diabetes mellitus. Nat. Rev. Dis. Primers 3, 17016 (2017).
DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers 1, 15019 (2015).
Pavlov, V. A. & Tracey, K. J. The vagus nerve and the inflammatory reflex-linking immunity and metabolism. Nat. Rev. Endocrinol. 8, 743–754 (2012).
Cotero, V. et al. Stimulation of the hepatoportal nerve plexus with focused ultrasound restores glucose homoeostasis in diabetic mice, rats and swine. Nat. Biomed. Eng. 6, 683–705 (2022).
Lackey, D. E. & Olefsky, J. M. Regulation of metabolism by the innate immune system. Nat. Rev. Endocrinol. 12, 15–28 (2016).
Borovikova, L. V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458–462 (2000).
Sha, B. et al. Doping-induced assembly interface for noninvasive in vivo local and systemic immunomodulation. Proc. Natl Acad. Sci. USA 120, e2306777120 (2023).
Kotb, M. A. et al. The vagus nerve cross-sectional area on ultrasound in patients with type 2 diabetes. Medicine 102, e36768 (2023).
Kim, Y. et al. A bioinspired flexible organic artificial afferent nerve. Science 360, 998–1003 (2018).
Wang, W. et al. Neuromorphic sensorimotor loop embodied by monolithically integrated, low-voltage, soft e-skin. Science 380, 735–742 (2023).
Ottaviani, M. M., Vallone, F., Micera, S. & Recchia, F. A. Closed-loop vagus nerve stimulation for the treatment of cardiovascular diseases: State of the art and future directions. Front. Cardiovasc. Med. 9, 866957 (2022).
Sun, F. T. & Morrell, M. J. Closed-loop neurostimulation: the clinical experience. Neurotherapeutics 11, 553–563 (2014).
Scangos, K. W. et al. Closed-loop neuromodulation in an individual with treatment-resistant depression. Nat. Med. 27, 1696–1700 (2021).
Oh, S. et al. Bioelectronic implantable devices for physiological signal recording and closed-loop neuromodulation. Adv. Funct. Mater. 34, 2403562 (2024).
Ben-Menachem, E. Vagus nerve stimulation, side effects, and long-term safety. J. Clin. Neurophysiol. 18, 415–418 (2001).
Bai, J. et al. Coin-sized, fully integrated, and minimally invasive continuous glucose monitoring system based on organic electrochemical transistors. Sci. Adv. 10, eadl1856 (2024).
Gao, W. et al. Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis. Nature 529, 509–514 (2016).
Ashrafi, G. & Ryan, T. A. Glucose metabolism in nerve terminals. Curr. Opin. Neurobiol. 45, 156–161 (2017).
Liu, Y. et al. Morphing electronics enable neuromodulation in growing tissue. Nat. Biotechnol. 38, 1031–1036 (2020).
Chen, J. et al. Glucose-oxidase like catalytic mechanism of noble metal nanozymes. Nat. Commun. 12, 3375 (2021).
Wu, J. & Yang, H. Platinum-based oxygen reduction electrocatalysts. Acc. Chem. Res. 46, 1848–1857 (2013).
Maity, D., Guha Ray, P., Buchmann, P., Mansouri, M. & Fussenegger, M. Blood-glucose-powered metabolic fuel cell for self-sufficient bioelectronics. Adv. Mater. 35, e2300890 (2023).
De la Paz, E. et al. A self-powered ingestible wireless biosensing system for real-time in situ monitoring of gastrointestinal tract metabolites. Nat. Commun. 13, 7405 (2022).
Lee, D. et al. Totally implantable enzymatic biofuel cell and brain stimulator operating in bird through wireless communication. Biosens. Bioelectron. 171, 112746 (2021).
Kang, J. et al. Tough and water-insensitive self-healing elastomer for robust electronic skin. Adv. Mater. 30, e1706846 (2018).
Friedel, M. et al. Opportunities and challenges in the diagnostic utility of dermal interstitial fluid. Nat. Biomed. Eng. 7, 1541–1555 (2023).
Sacks, D. B. et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin. Chem. 48, 436–472 (2002).
Furman, B. L. Streptozotocin-induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. 70, 5.47.41–45.47.20 (2015).
Wang, H. et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421, 384–388 (2003).
Pavlov, V. A., Wang, H., Czura, C. J., Friedman, S. G. & Tracey, K. J. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol. Med. 9, 125–134 (2003).
Van Goethem, N. P. et al. Antagonizing α7 nicotinic receptors with methyllycaconitine (mla) potentiates receptor activity and memory acquisition. Cell Signal. 62, 109338 (2019).
Xu, J., Li, P., Wang, G. E., Ye, D. & Tang, X. A 7nachr inhibition by methyllycaconitine citrate promotes cell pyroptosis by triggering the polyol pathway in cervical cancer cells. Biocell 48, 283–291 (2024).
Waise, T. M. Z., Dranse, H. J. & Lam, T. K. T. The metabolic role of vagal afferent innervation. Nat. Rev. Gastroenterol. Hepatol. 15, 625–636 (2018).
Assaad, H. et al. Analysis of energy expenditure in diet-induced obese rats. Front. Biosci. 19, 967–985 (2014).
Martínez-Reyes, I. & Chandel, N. S. Mitochondrial tca cycle metabolites control physiology and disease. Nat. Commun. 11, 102 (2020).
Dungan, K. M. 1,5-anhydroglucitol (glycomark™) as a marker of short-term glycemic control and glycemic excursions. Expert Rev. Mol. Diagn. 8, 9–19 (2008).
Bergman, B. C. et al. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans. Am. J. Physiol. 309, E398–E408 (2015).
Prawitt, J., Caron, S. & Staels, B. Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr. Diabetes Rep. 11, 160–166 (2011).
Pavlov, V. A. & Tracey, K. J. Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem. Soc. Trans. 34, 1037–1040 (2006).
Hoxhaj, G. & Manning, B. D. The pi3k-akt network at the interface of oncogenic signalling and cancer metabolism. Nat. Rev. Cancer 20, 74–88 (2020).
Koprivica, I., Stanisavljevic, S., Micanovic, D., Stojanovic, I. & Miljkovic, D. Multiple low dose streptozotocin-induced diabetes as a model for studying autoimmune diabetes in humans. Anim. Models Exp. Med. 8, 1539–1551 (2025).
Imai, J. et al. Regulation of pancreatic β cell mass by neuronal signals from the liver. Science 322, 1250–1254 (2008).
Yamamoto, J. et al. Neuronal signals regulate obesity induced beta-cell proliferation by foxm1 dependent mechanism. Nat. Commun. 8, 1930 (2017).
Yin, L. et al. A passive perspiration biofuel cell: high energy return on investment. Joule 5, 1888–1904 (2021).
Hanley, A. J. G., Williams, K., Stern, M. P. & Haffner, S. M. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio heart study. Diabetes Care 25, 1177–1184 (2002).